The Problem

Zicam advertised its pre-cold medicines as preventing, shortening and reducing the severity of the symptoms of the common cold.

What We Did

We filed a class action lawsuit on behalf of purchasers of Zicam pre-cold medicines in the United States alleging that the claims about Zicam were false and misleading and seeking refunds for purchasers.  On the eve of trial, we negotiated a $16 million class settlement.

What Our Clients Got

The Court awarded the plaintiff a $10,000 incentive award.  Class members received a full cash refund for up to five units of Zicam without proof of purchase.  Class members received a full cash refund for six or more units purchased with proof of purchase.